Patents by Inventor Seoung-Soo Hong

Seoung-Soo Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMAGE ENCODER AND DECODER USING UNIDIRECTIONAL PREDICTION
    Publication number: 20240107032
    Abstract: The present invention relates to an image encoding and decoding technique, and more particularly, to an image encoder and decoder using unidirectional prediction. The image encoder includes a dividing unit to divide a macro block into a plurality of sub-blocks, a unidirectional application determining unit to determine whether an identical prediction mode is applied to each of the plurality of sub-blocks, and a prediction mode determining unit to determine a prediction mode with respect to each of the plurality of sub-blocks based on a determined result of the unidirectional application determining unit.
    Type: Application
    Filed: December 7, 2023
    Publication date: March 28, 2024
    Applicants: Electronics and Telecommunications Research Institute, Kwangwoon University Industry-Academic Collaboration Foundation, University-Industry Cooperation Group of Kyung Hee University
    Inventors: Hae Chul CHOI, Se Yoon JEONG, Sung-Chang LIM, Jin Soo CHOI, Jin Woo HONG, Dong Gyu SIM, Seoung-Jun OH, Chang-Beom AHN, Gwang Hoon PARK, Seung Ryong KOOK, Sea-Nae PARK, Kwang-Su JEONG
  • SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20220000830
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Application
    Filed: July 12, 2021
    Publication date: January 6, 2022
    Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: James T. Dalton, Thomas G. BIRD, Tai AHN, David A. DICKASON, Seoung-Soo HONG
  • Solid forms of selective androgen receptor modulators
    Patent number: 11090283
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: August 17, 2021
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: James T. Dalton, Thomas G. Bird, Tai Ahn, David A. Dickason, Seoung-Soo Hong
  • SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20170266149
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Application
    Filed: November 24, 2016
    Publication date: September 21, 2017
    Applicant: GTx, Inc.
    Inventors: James T. DALTON, Thomas G. BIRD, Tai AHN, David A. DICKASON, Seoung-Soo HONG
  • Estrogen receptor ligands and methods of use thereof
    Patent number: 9409856
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBA compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including, inter alia, prevention and treatment of hormone-related diseases, cancers, inflammation, osteoporosis, peripheral vascular disease, reducing circulating lipid levels, and cardiovascular disease.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: August 9, 2016
    Assignee: Gtx, Inc.
    Inventors: James T. Dalton, Christina Herring, Duane D. Miller, Seoung-Soo Hong, Yali He, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20160128969
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Application
    Filed: October 5, 2015
    Publication date: May 12, 2016
    Inventors: James T. DALTON, Thomas G. BIRD, Tai AHN, David A. DICKASON, Seoung-Soo HONG
  • ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF
    Publication number: 20160031797
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBA compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including, inter alia, prevention and treatment of hormone-related diseases, cancers, inflammation, osteoporosis, peripheral vascular disease, reducing circulating lipid levels, and cardiovascular disease.
    Type: Application
    Filed: June 8, 2015
    Publication date: February 4, 2016
    Inventors: James T. DALTON, Christina Herring, Duane D. MILLER, Seoung-Soo HONG, Yali HE, Michael L. MOHLER, Ramesh NARAYANAN, Zhongzhi WU
  • Solid forms of selective androgen receptor modulators
    Patent number: 9150501
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: October 6, 2015
    Assignee: GTx, Inc.
    Inventors: James T. Dalton, Thomas G. Bird, Tai Ahn, David A. Dickason, Seoung-Soo Hong
  • Nuclear receptor binding agents
    Patent number: 9078888
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: July 14, 2015
    Assignee: GTX, INC.
    Inventors: James T. Dalton, Duane D. Miller, Michael L. Mohler, Seoung-Soo Hong, Zhongzhi Wu, Devesh Srivastava
  • SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20140051764
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 20, 2014
    Inventors: James T. Dalton, Thomas G. Bird, Tai Ahn, David A. Dickason, Seoung-Soo Hong
  • Nuclear receptor binding agents
    Patent number: 8637706
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: January 28, 2014
    Assignee: Gtx, Inc.
    Inventors: James T. Dalton, Christina Barrett, Duane D. Miller, Seoung-Soo Hong, Yali He, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • Solid forms of selective androgen receptor modulators
    Patent number: 8563606
    Abstract: The present invention relates to solid forms of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Grant
    Filed: June 5, 2011
    Date of Patent: October 22, 2013
    Assignee: GTx, Inc.
    Inventors: James T. Dalton, David A. Dickason, Seoung-Soo Hong, Thomas G. Bird, Tai Ahn
  • NUCLEAR RECEPTOR BINDING AGENTS
    Publication number: 20120157539
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Application
    Filed: January 31, 2012
    Publication date: June 21, 2012
    Inventors: James T. DALTON, Christina BARRETT, Duane D. MILLER, Seoung-Soo HONG, Yali HE, Michael L. MOHLER, Ramesh NARAYANAN, Zhongzhi WU
  • Nuclear receptor binding agents
    Patent number: 8158828
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: April 17, 2012
    Assignee: GTx, Inc.
    Inventors: James T. Dalton, Christina Barrett, Yali He, Seoung-Soo Hong, Duane D. Miller, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20110263703
    Abstract: The present invention relates to solid forms of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Application
    Filed: June 5, 2011
    Publication date: October 27, 2011
    Inventors: James T. Dalton, David A. Dickason, Seoung-Soo Hong, Thomas G. Bird, Tai Ahn
  • Solid forms of selective androgen receptor modulators
    Patent number: 7968603
    Abstract: The present invention relates to solid forms of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: June 28, 2011
    Assignee: University of Tennessee Research Foundation
    Inventors: James T. Dalton, David A. Dickason, Seoung-Soo Hong, Thomas G. Bird, Tai Ahn
  • SOLID FORMS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS
    Publication number: 20100022641
    Abstract: The present invention relates to solid forms of (S)—N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
    Type: Application
    Filed: September 29, 2008
    Publication date: January 28, 2010
    Inventors: James T. Dalton, David A. Dickason, Seoung-Soo Hong, Thomas G. Bird, Tai Ahn
  • Nuclear receptor binding agents
    Publication number: 20090062341
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Application
    Filed: November 28, 2006
    Publication date: March 5, 2009
    Inventors: James T. Dalton, Christina Barrett, Yali He, Seoung-Soo Hong, Duane D. Miller, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • Nuclear receptor binding agents
    Publication number: 20090030036
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity.
    Type: Application
    Filed: January 22, 2008
    Publication date: January 29, 2009
    Inventors: James T. Dalton, Duane D. Miller, Michael L. Mohler, Seoung-Soo Hong, Zhongzhi Wu, Devesh Srivastava
  • Nuclear receptor binding agents
    Publication number: 20070265296
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Application
    Filed: April 16, 2007
    Publication date: November 15, 2007
    Inventors: James Dalton, Christina Barrett, Yali He, Seoung-Soo Hong, Duane Miller, Michael Mohler, Ramesh Narayanan, Zhongzhi Wu